A detailed history of O'Shaughnessy Asset Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 9,752 shares of ARWR stock, worth $245,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,752
Previous 9,896 1.46%
Holding current value
$245,945
Previous $302,000 7.95%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$27.21 - $39.48 $3,918 - $5,685
-144 Reduced 1.46%
9,752 $278,000
Q4 2023

Feb 09, 2024

BUY
$21.2 - $31.03 $7,165 - $10,488
338 Added 3.54%
9,896 $302,000
Q3 2023

Nov 13, 2023

BUY
$26.2 - $36.08 $250,419 - $344,852
9,558 New
9,558 $256,000
Q1 2023

May 12, 2023

SELL
$23.68 - $38.51 $39,143 - $63,657
-1,653 Reduced 14.17%
10,014 $254,000
Q4 2022

Feb 10, 2023

SELL
$28.0 - $40.56 $11,452 - $16,589
-409 Reduced 3.39%
11,667 $473,000
Q3 2022

Nov 14, 2022

BUY
$29.63 - $48.31 $70,282 - $114,591
2,372 Added 24.44%
12,076 $399,000
Q2 2022

Aug 11, 2022

BUY
$27.79 - $50.61 $9,059 - $16,498
326 Added 3.48%
9,704 $342,000
Q1 2022

May 13, 2022

BUY
$39.62 - $69.97 $84,549 - $149,315
2,134 Added 29.46%
9,378 $431,000
Q4 2021

Feb 11, 2022

BUY
$58.09 - $82.51 $69,940 - $99,342
1,204 Added 19.93%
7,244 $480,000
Q3 2021

Nov 10, 2021

SELL
$58.38 - $84.96 $31,058 - $45,198
-532 Reduced 8.09%
6,040 $378,000
Q1 2021

May 14, 2021

SELL
$61.35 - $90.47 $6,319 - $9,318
-103 Reduced 1.54%
6,572 $435,000
Q4 2020

Feb 11, 2021

SELL
$43.82 - $85.37 $218,880 - $426,423
-4,995 Reduced 42.8%
6,675 $512,000
Q3 2020

Nov 12, 2020

SELL
$33.21 - $51.27 $39,021 - $60,242
-1,175 Reduced 9.15%
11,670 $504,000
Q2 2020

Aug 13, 2020

SELL
$26.12 - $43.27 $75,669 - $125,353
-2,897 Reduced 18.4%
12,845 $555,000
Q1 2020

May 13, 2020

BUY
$20.56 - $63.12 $28,434 - $87,294
1,383 Added 9.63%
15,742 $455,000
Q4 2019

Feb 12, 2020

BUY
$28.14 - $73.01 $404,062 - $1.05 Million
14,359 New
14,359 $909,000
Q1 2019

May 10, 2019

SELL
$12.05 - $20.18 $2,916 - $4,883
-242 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$10.74 - $19.7 $2,599 - $4,767
242 New
242 $3,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.67B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.